Pauline Kostelac, DO
Family Medicine · Mechanicsburg, PANPI 1336177443
Payments from drug & device makers
Across 114 payments — averaging $18.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$287
- Novo Nordisk$270
- Pfizer$256
- GSK$238
- AbbVie$181
- Abbott$146
- plus $706 from 16 others
What the payments were for
- Food & beverage$2,083100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 16 | $287 |
| Novo Nordisk | 15 | $270 |
| Pfizer | 16 | $256 |
| GSK | 13 | $238 |
| AbbVie | 8 | $181 |
| Abbott | 2 | $146 |
| Amgen | 7 | $120 |
| Merck | 6 | $89 |
| Biohaven Pharmaceuticals, Inc. | 4 | $66 |
| AstraZeneca | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $56 |
| Boehringer Ingelheim | 3 | $54 |
| Sanofi Pasteur Inc. | 3 | $47 |
| Exact Sciences | 2 | $35 |
| Johnson & Johnson | 2 | $32 |
| Amarin Pharma, Inc. | 2 | $31 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Bayer | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Eisai Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,083 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 80 | $86,698 |
| EliquisApixaban | 40 | $45,332 |
| TrulicityDulaglutide | 19 | $42,923 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $31,752 |
| XareltoRivaroxaban | 22 | $19,219 |
| RybelsusSemaglutide | 13 | $11,843 |
| Atorvastatin Calcium | 415 | $7,636 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $7,118 |
| Rosuvastatin Calcium | 271 | $6,248 |
| Colesevelam Hcl | 12 | $4,708 |
| Valsartan | 72 | $3,559 |
| Levothyroxine Sodium | 263 | $3,406 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 77 | $3,071 |
| Potassium Chloride | 114 | $2,283 |
| Lisinopril | 328 | $2,188 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $54 | $86,69880 claims |
| PfizerEliquis | $256 | $45,33240 claims |
| Lilly USA, LLCTrulicity | $287 | $42,92319 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $238 | $38,87049 claims |
| Johnson & JohnsonXarelto | $32 | $19,21922 claims |
| Novo NordiskRybelsus | $270 | $11,84313 claims |
| AbbVieSynthroid | $181 | $1,65846 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Mechanicsburg
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.